Interv Akut Kardiol. 2018;17(3):144-147 | DOI: 10.36290/kar.2018.013
Objective: To monitor the proportion of patients with the diagnosis of arrhythmogenic right ventricular dysplasia (ARVD) indicatedfor ICD implantation.
Method: The authors describe the incidence of ARVD in a population during a six-year period and monitor the clinical manifestationsin patients with this diagnosis as well as the examination methods and, subsequently, the rate of arrhythmias.
Results: Our cohort comprised 6 patients with ARVD, with all of them having symptoms indicative of a haemodynamically significantventricular arrhythmia manifested by syncopal or presyncopal states. As evidenced by echocardiography, all the patientshad right ventricular dilation, which was confirmed by x-ray changes in 5 patients. These patients were indicated for implantablecardioverter defibrillator (ICD) placement according to the guidelines. During follow-up, haemodynamically significant ventriculararrhythmias were detected in 4 patients, of whom 3 patients were indicated for radiofrequency catheter ablation of a substratefrom the right ventricle due to recurrent ventricular arrhythmia.
Conclusion: Although a rare condition, the diagnosis of ARVD must be considered in patients with a history of syncope, presyncopalstates, or palpitations, particularly with exertion at a young age. In these patients, at least, radiographic and echocardiographicevaluation should be performed.
Received: July 16, 2018; Accepted: July 16, 2018; Published: October 1, 2018 Show citation
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...